Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, MD, Young-Shin Lee, RN, Soo-Kyung Sim, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 1464.

https://doi.org/10.1182/blood.V110.11.1464.1464

Published: 2007

Journal Articles

C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.

Michael Jinpyo Lee, Eun-Hye Hur, MS, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun-Hee Kim, RN, Hee-Jung Lee, RN, Ip-Sol Kang, RN, Kyung-Soo Shim, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Young-Shin Lee, RN, Chan-Jeoung Park, MD, Hyung-Sook Chi, MD, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 2381.

https://doi.org/10.1182/blood.V110.11.2381.2381

Published: 2007

Journal Articles

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Blood (2007) 110 (11): 1833.

https://doi.org/10.1182/blood.V110.11.1833.1833

Published: 2007

Journal Articles

Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Young-Shin Lee, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 5042.

https://doi.org/10.1182/blood.V110.11.5042.5042

Published: 2007

Journal Articles

Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Young-Shin Lee, RN, Seong-Gil Ryu, RPh, Young-Ah Kang, RN, Kyoo-Hyung Lee, MD

Blood (2007) 110 (11): 4974.

https://doi.org/10.1182/blood.V110.11.4974.4974

Published: 2007

Journal Articles

HLA-Haploidentical Familial Donor Hematopoietic Cell Transplantation without Ex Vivo- T Cell Depletion after Reduced-Intensity Conditioning of Busulfan, Fludarabine, and Anti-Thymocyte Globulin: A Preliminary Report.

Kyoo-Hyung Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Ho-Jin Shin, MD, Young-Shin Lee, RN, Young-Ah Kang, RN, Miee Seol, RN, Seong-Gil Ryu, BS, Je-Hwan Lee, MD

Blood (2007) 110 (11): 3077.

https://doi.org/10.1182/blood.V110.11.3077.3077

Published: 2007

Journal Articles

Antithymocyte Globulin (ATG) Plus Cyclosporine (CSA) for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS).

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun Hee Kim, RN, Jae-Hoo Park, MD, Hawk Kim, MD, Young-Don Joo, MD, Won-Sik Lee, MD, Dae Young Zang, MD, Hyo Jung Kim, MD, Kyoo Hyung Lee, MD

Blood (2006) 108 (11): 3777.

https://doi.org/10.1182/blood.V108.11.3777.3777

Published: 2006

Journal Articles

Hypoplastic Acute Myeloid Leukemia.

Hye-Won Park, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Young-Shin Lee, RN, Seong-Gil Ryu, RPh, Keun Hee Kim, RN, Seongsoo Jang, MD, Eul-Joo Seo, MD, Chan-Jeoung Park, MD, Hyun-Sook Chi, MD, Jung-Shin Lee, MD, M. Wookun Kim, MD, Kyoo Hyung Lee, MD

Blood (2006) 108 (11): 4493.

https://doi.org/10.1182/blood.V108.11.4493.4493

Published: 2006

Journal Articles

Randomized Comparison of 4-Times-Daily Versus Once-Daily Intravenous Busulfan in a Conditioning Therapy for Hematopoietic Cell Transplantation (HCT).

Seong-Gil Ryu, RPh, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Young-Shin Lee, RN, Miee Seol, RN, Eun-Hye Hur, MS, Soo Han Lee, MD, Kyun Seop Bae, MD, Gyu Jeong Noh, MD, Moo-Song Lee, MD, SungCheol Yun, PhD, Sang Beom Han, PhD, Kyoo Hyung Lee, MD

Blood (2006) 108 (11): 2938.

https://doi.org/10.1182/blood.V108.11.2938.2938

Published: 2006

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Leukemia in First Relapse or Second Remission.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Young-Shin Lee, RN, SungCheol Yun, PhD, Sung-Soo Yoon, MD, Inho Kim, MD, Seonyang Park, MD, Byoung Kook Kim, MD, Chul Won Jung, MD, Kihyun Kim, MD, Jin Seok Ahn, MD, Kyoo-Hyung Lee, MD

Blood (2005) 106 (11): 5415.

https://doi.org/10.1182/blood.V106.11.5415.5415

Published: 2005

Journal Articles

Standard Induction Followed by Attenuated Consolidation Therapy in Elderly Patients with Acute Myeloid Leukemia.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun Hee Kim, RN, Jae-Hoo Park, MD, Hawk Kim, MD, Young-Don Joo, MD, Won Sik Lee, MD, Dae Young Zang, MD, Hyo Jung Kim, MD, Kyoo-Hyung Lee, MD, Cooperative Study Group A for Hematology

Blood (2005) 106 (11): 4602.

https://doi.org/10.1182/blood.V106.11.4602.4602

Published: 2005

Journal Articles

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Dong Hwan Kim, MD, Sang Kyun Sohn, MD, Kun Soo Lee, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5335.

https://doi.org/10.1182/blood.V106.11.5335.5335

Published: 2005

Journal Articles

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Sang Kyun Sohn, MD, Dong Hwan Kim, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5337.

https://doi.org/10.1182/blood.V106.11.5337.5337

Published: 2005

Journal Articles

Non-Total Body Irradiation (TBI) Containing Preparative Regimen in Alternative Donor Bone Marrow Transplantation (BMT) for Severe Aplastic Anemia (SAA).

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Young-Shin Lee, RN, Miee Seol, RN, Jung-Shin Lee, MD, M. Wookun Kim, MD, Kyoo Hyung Lee, MD

Blood (2004) 104 (11): 2766.

https://doi.org/10.1182/blood.V104.11.2766.2766

Published: 2004

NARROW

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.

C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.

Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.

HLA-Haploidentical Familial Donor Hematopoietic Cell Transplantation without Ex Vivo- T Cell Depletion after Reduced-Intensity Conditioning of Busulfan, Fludarabine, and Anti-Thymocyte Globulin: A Preliminary Report.

Antithymocyte Globulin (ATG) Plus Cyclosporine (CSA) for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS).

Hypoplastic Acute Myeloid Leukemia.

Randomized Comparison of 4-Times-Daily Versus Once-Daily Intravenous Busulfan in a Conditioning Therapy for Hematopoietic Cell Transplantation (HCT).

Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Leukemia in First Relapse or Second Remission.

Standard Induction Followed by Attenuated Consolidation Therapy in Elderly Patients with Acute Myeloid Leukemia.

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Non-Total Body Irradiation (TBI) Containing Preparative Regimen in Alternative Donor Bone Marrow Transplantation (BMT) for Severe Aplastic Anemia (SAA).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only